Internal Medicine, Hematology & Oncology · Portland, OR
NPI
1922001023
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
9555 SW Barnes Rd, Ste 150
Portland, OR, 97225
Phone (503) 297-7403
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
102,012 services
Medicare patients, 2024
411
Average age 73
Drug cost, 2024
$2.6M
1,254 prescriptions
Company payments, 2025
$78.1
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jay C Andersen was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 15,700 times for 24 patients. In total Jay C Andersen billed 102,012 services in 171 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 15,700 | 24 | $2.33 | $37K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 11,220 | 16 | $0.25 | $2,848 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 10,201 | 21 | $44.74 | $456K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 5,100 | 18 | $0.11 | $547 |
| J9267 Injection, paclitaxel, 1 mg | Office | 4,254 | 11 | $0.08 | $337 |
| J0185 Injection, aprepitant, 1 mg | Office | 4,030 | 22 | $1.34 | $5,419 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 3,025 | 30 | $0.10 | $315 |
| Q5129 Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg | Office | 1,880 | 13 | $49.69 | $93K |
| Q5116 Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg | Office | 1,029 | 11 | $11.60 | $12K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 959 | 42 | $0.09 | $84.85 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 800 | 33 | $0.25 | $203 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 691 | 39 | $0.73 | $506 |
| 85025 Blood Count | Office | 462 | 128 | $7.60 | $3,510 |
| 80053 Clinical Chemistry | Office | 410 | 126 | $10.33 | $4,235 |
| J9045 Injection, carboplatin, 50 mg | Office | 331 | 22 | $2.85 | $942 |
By year: 2022 $1.2M for 87,775 services; 2023 $1.1M for 78,237 services; 2024 $1.5M for 102,012 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 462 | 128 | $7.60 | $3,510 |
| 80053 Clinical Chemistry | 410 | 126 | $10.33 | $4,235 |
| 36415 Venipuncture Blood Collection | 323 | 126 | $8.62 | $2,785 |
| 82378 Clinical Chemistry | 208 | 81 | $18.51 | $3,850 |
| 86300 Immunoassay | 195 | 82 | $20.31 | $3,959 |
| 82784 Immunoassay | 151 | 31 | $9.11 | $1,376 |
| 82728 Clinical Chemistry | 107 | 50 | $13.36 | $1,430 |
| 83550 Clinical Chemistry | 105 | 48 | $8.57 | $900 |
| 83540 Clinical Chemistry | 105 | 48 | $6.34 | $666 |
| 82306 Clinical Chemistry | 83 | 60 | $29.01 | $2,408 |
Medicare prescription drug claims, 2024
In 2024, the drug Jay C Andersen prescribed most often to Medicare patients was Letrozole, with 267 prescriptions and refills. In total Jay C Andersen wrote 1,254 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 267 | 767 | 93 | $6,629 |
| Anastrozole Generic | 182 | 525 | 59 | $3,338 |
| Tamoxifen Citrate Generic | 116 | 304 | 37 | $4,163 |
| Folic Acid Generic | 54 | 138 | 15 | $458 |
| Eliquis Apixaban | 45 | 61 | 13 | $34K |
| Gabapentin Generic | 41 | 74 | 11 | $420 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 40 | 105 | Under 11 | $658 |
| Ondansetron Hcl Generic | 34 | 34 | 22 | $193 |
| Prochlorperazine Maleate Generic | 29 | 29 | 19 | $256 |
| Ibrance Palbociclib | 28 | 28 | Under 11 | $434K |
| Verzenio Abemaciclib | 25 | 25 | Under 11 | $367K |
| Lenalidomide Generic | 24 | 24 | Under 11 | $208K |
| Estradiol Generic | 22 | 63 | Under 11 | $1,840 |
| Trazodone Hcl Generic | 21 | 43 | Under 11 | $147 |
| Exemestane Generic | 21 | 57 | Under 11 | $4,553 |
Brand drugs: 204 claims; generic drugs: 1,050 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jay C Andersen $78.1 ($78.1 in general payments such as food, travel and fees) from 8 companies. The largest payer was Astellas Pharma US Inc with $37.61.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.